107 related articles for article (PubMed ID: 8538925)
1. T-lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood.
Neuhaus TJ; Shah V; Callard RE; Barratt TM
Nephrol Dial Transplant; 1995; 10(8):1348-52. PubMed ID: 8538925
[TBL] [Abstract][Full Text] [Related]
2. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome.
Daniel V; Trautmann Y; Konrad M; Nayir A; Schärer K
Clin Nephrol; 1997 May; 47(5):289-97. PubMed ID: 9181275
[TBL] [Abstract][Full Text] [Related]
3. [Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results].
Musiał K; Ciszak L; Kosmaczewska A; Szteblich A; Pawlak E; Zwolińska D; Frydecka I
Przegl Lek; 2006; 63 Suppl 3():208-10. PubMed ID: 16898532
[TBL] [Abstract][Full Text] [Related]
4. T-lymphocyte populations and cytokines in childhood nephrotic syndrome.
Lama G; Luongo I; Tirino G; Borriello A; Carangio C; Salsano ME
Am J Kidney Dis; 2002 May; 39(5):958-65. PubMed ID: 11979339
[TBL] [Abstract][Full Text] [Related]
5. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
Tkaczyk M; Owczarek D; Finke D; Nowicki M
Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
[TBL] [Abstract][Full Text] [Related]
6. Changes of lymphocyte populations in pediatric steroid-sensitive nephrotic syndrome are more pronounced in remission than in relapse.
Kemper MJ; Zepf K; Klaassen I; Link A; Muller-Wiefel DE
Am J Nephrol; 2005; 25(2):132-7. PubMed ID: 15855740
[TBL] [Abstract][Full Text] [Related]
7. IL-18 is correlated with type-2 immune response in children with steroid sensitive nephrotic syndrome.
Printza N; Papachristou F; Tzimouli V; Taparkou A; Kanakoudi-Tsakalidou F
Cytokine; 2008 Nov; 44(2):262-8. PubMed ID: 18819819
[TBL] [Abstract][Full Text] [Related]
8. Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome.
El-Melegy NT; Mohamed NA; Sayed MM
Pediatr Res; 2008 Apr; 63(4):404-9. PubMed ID: 18356747
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
10. Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome.
Kemper MJ; Meyer-Jark T; Lilova M; Müller-Wiefel DE
Clin Nephrol; 2003 Oct; 60(4):242-7. PubMed ID: 14579938
[TBL] [Abstract][Full Text] [Related]
11. [Interleukin-18 expression in peripheral blood mononuclear cells in children with steroid-resistant nephrotic syndrome].
Jiang HK; Luo G; Jiang H
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):337-40. PubMed ID: 19470251
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A.
Wasilewska A; Zoch-Zwierz W; Tenderenda E
Acta Paediatr; 2006 Mar; 95(3):291-6. PubMed ID: 16497638
[TBL] [Abstract][Full Text] [Related]
13. T cell activation in patients with ANCA-associated vasculitis: inefficient immune suppression by therapy.
Christensson M; Pettersson E; Sundqvist KG; Christensson B
Clin Nephrol; 2000 Dec; 54(6):435-42. PubMed ID: 11140803
[TBL] [Abstract][Full Text] [Related]
14. Implications of blood soluble and cell surface tumor necrosis factor receptors in childhood nephrotic syndrome.
Tain YL; Liu CA; Yang KD
Pediatr Nephrol; 2002 Nov; 17(11):926-32. PubMed ID: 12432436
[TBL] [Abstract][Full Text] [Related]
15. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
[TBL] [Abstract][Full Text] [Related]
16. T-cell subpopulations in childhood nephrotic syndrome.
Kobayashi K; Yoshikawa N; Nakamura H
Clin Nephrol; 1994 May; 41(5):253-8. PubMed ID: 8050203
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukine-2 receptor and MDR1 gene expression levels as inflammatory biomarkers for prediction of steroid response in children with nephrotic syndrome.
Youssef DM; Elbehidy RM; Abdelhalim HS; Amr GE
Iran J Kidney Dis; 2011 Jul; 5(3):154-61. PubMed ID: 21525574
[TBL] [Abstract][Full Text] [Related]
18. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF; Brodeh J
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[TBL] [Abstract][Full Text] [Related]
19. Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
Fakhouri F; Bocquet N; Taupin P; Presne C; Gagnadoux MF; Landais P; Lesavre P; Chauveau D; Knebelmann B; Broyer M; Grünfeld JP; Niaudet P
Am J Kidney Dis; 2003 Mar; 41(3):550-7. PubMed ID: 12612977
[TBL] [Abstract][Full Text] [Related]
20. [Immunologic state and effect of long-term levamisole therapy on selected immunologic parameters in children with steroid sensitive nephrotic syndrome during remission].
Prandota J; Jankowski A; Szozda A
Pol Tyg Lek; 1993 May 17-31; 48(20-22):455-9. PubMed ID: 8170809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
